Early Phase Focus CBOI specializes in early phase immunotherapy trials and operates a regional Phase I access hub, presenting opportunities to offer collaborative trial support services, regulatory consulting, and patient recruitment partnerships to biotechs seeking Phase I infrastructure.

Integrated BioCytics With BioCytics handling internal research, process development, and cGMP manufacturing, there is potential to provide external CDMO services, process optimization, and manufacturing scale-up support to partners pursuing personalized cell therapies.

Genomics Collaboration Recent joint initiatives with BioCytics and UNC Charlotte to identify genomic features indicate a pathway for joint research programs, grant collaborations, and data-driven biomarker or companion diagnostic opportunities.

Growth and Partnerships Strategic partnerships with industry entities like XcellBio in the past and ongoing expansion signals offer avenues to pitch collaboration on preclinical to early clinical development, as well as access to a dedicated Phase I patient population.

Regional Access Gateway Serving as a regional Phase I access hub in the East Coast and treating thousands of patients, CBOI presents sales opportunities for ancillary services such as trial logistics, regulatory affairs support, CLIA/COLA-compliant data handling, and patient navigation solutions.